Filing Details

Accession Number:
0001562180-23-006433
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-18 16:03:38
Reporting Period:
2023-08-16
Accepted Time:
2023-08-18 16:03:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822462 Foghorn Therapeutics Inc. FHTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1748961 Samuel Agresta 500 Technology Square
Ste 700
Cambridge MA 02139
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-16 311,297 $3.72 311,297 No 4 M Direct
Common Stock Disposition 2023-08-16 311,297 $8.25 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-08-16 311,297 $0.00 311,297 $3.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2029-09-16 No 4 M Direct
Footnotes
  1. The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested.